Skip to content

Schema Therapy for Dissociative Identity Disorder

Schema Therapy for Dissociative Identity Disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25486
Enrollment
32
Registered
2021-06-30
Start date
2021-06-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dissociative Identity Disorder

Interventions

A form of schema therapy, adapted to the needs of the patients with Dissociative Identity Disorder

Sponsors

University of Groningen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Main diagnosis of Dissociative Identity Disorder, diagnosed with the SCID-D-R • The initial Dissociative Identity Disorder diagnosis was classified max 3 years ago • Participant has not received schema therapy before • Participant has not completed successful trauma treatment • Participant is motivated to undertake trauma treatment and to actively participate in achieving the treatment goals (reading literature at home, doing home assignments etc.) and to practice behavioral change • Participant agrees to be recorded; in diagnostic interviews on video and treatment sessions on audio • Age = 18 and < 60 • Participant is able to understand, read, write, and speak Dutch

Exclusion criteria

Exclusion criteria: • DSM-5 substance dependence, as measured with the MINI-plus, that requires detox • Florid psychotic episodes, as determined with the MINI-plus • Acute suicide risk, as measured with several questions on suicidal behavior, which are administered as part of the intake. • IQ < 80. IQ testing is requested by default by the intaker when education level is lower than intermediate vocational education. In that case, the screener for intelligence and mild intellectual disability (SCIL) is administered, with further IQ tests (WAIS) if indicated • Other comorbid Axis I and Axis II disorders are allowed. They will be classified with the MINI-plus and the SCID-5-PD

Design outcomes

Primary

MeasureTime frame
Dissociative symptoms (DSS), Post Traumatic Stress Disorder symptoms (PCL-5), Symptoms clusters of Dissociative Identity Disorder: depersonalisation, derealisation, identity confusion and amnesia (SCID-D-R), therapy dropout percentage.

Secondary

MeasureTime frame
Trait dissociation (DES), a selection of validity scales from the Multidimensional Inventory of Dissociation (MID), metamemory beliefs (DBMQ), unusual sleep experiences (ISES), personality functioning and personality traits (SIPP-SF, PID-5-Brief Form), outcomes related to schema therapy (YSQ3-SF, SMI-2), daily functioning (WHODAS 2.0), happiness, quality of therapeutic relation (WAI-SR) and experiential avoidance (AAQ-II).

Contacts

Public ContactRobin van der Linde

Rijksuniversiteit Groningen

r.van.der.linde@rug.nl0650899472

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)